338 related articles for article (PubMed ID: 28125901)
1. OneBac 2.0: Sf9 Cell Lines for Production of AAV1, AAV2, and AAV8 Vectors with Minimal Encapsidation of Foreign DNA.
Mietzsch M; Hering H; Hammer EM; Agbandje-McKenna M; Zolotukhin S; Heilbronn R
Hum Gene Ther Methods; 2017 Feb; 28(1):15-22. PubMed ID: 28125901
[TBL] [Abstract][Full Text] [Related]
2. OneBac 2.0: Sf9 Cell Lines for Production of AAV5 Vectors with Enhanced Infectivity and Minimal Encapsidation of Foreign DNA.
Mietzsch M; Casteleyn V; Weger S; Zolotukhin S; Heilbronn R
Hum Gene Ther; 2015 Oct; 26(10):688-97. PubMed ID: 26134901
[TBL] [Abstract][Full Text] [Related]
3. OneBac: platform for scalable and high-titer production of adeno-associated virus serotype 1-12 vectors for gene therapy.
Mietzsch M; Grasse S; Zurawski C; Weger S; Bennett A; Agbandje-McKenna M; Muzyczka N; Zolotukhin S; Heilbronn R
Hum Gene Ther; 2014 Mar; 25(3):212-22. PubMed ID: 24299301
[TBL] [Abstract][Full Text] [Related]
4. Development of Versatile and Flexible Sf9 Packaging Cell Line-Dependent OneBac System for Large-Scale Recombinant Adeno-Associated Virus Production.
Wu Y; Mei T; Jiang L; Han Z; Dong R; Yang T; Xu F
Hum Gene Ther Methods; 2019 Oct; 30(5):172-183. PubMed ID: 31566024
[TBL] [Abstract][Full Text] [Related]
5. Popularizing Recombinant Baculovirus-derived OneBac System for Laboratory Production of all Recombinant Adeno-associated Virus Vector Serotypes.
Wu Y; Han Z; Duan M; Jiang L; Tian T; Jin D; Wang Q; Xu F
Curr Gene Ther; 2021; 21(2):167-176. PubMed ID: 33461466
[TBL] [Abstract][Full Text] [Related]
6. Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids.
Mietzsch M; Eddington C; Jose A; Hsi J; Chipman P; Henley T; Choudhry M; McKenna R; Agbandje-McKenna M
J Virol; 2021 Sep; 95(19):e0077321. PubMed ID: 34287038
[TBL] [Abstract][Full Text] [Related]
7. Relevance of Assembly-Activating Protein for Adeno-associated Virus Vector Production and Capsid Protein Stability in Mammalian and Insect Cells.
Grosse S; Penaud-Budloo M; Herrmann AK; Börner K; Fakhiri J; Laketa V; Krämer C; Wiedtke E; Gunkel M; Ménard L; Ayuso E; Grimm D
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768875
[TBL] [Abstract][Full Text] [Related]
8. Origins of truncated supplementary capsid proteins in rAAV8 vectors produced with the baculovirus system.
Galibert L; Savy A; Dickx Y; Bonnin D; Bertin B; Mushimiyimana I; van Oers MM; Merten OW
PLoS One; 2018; 13(11):e0207414. PubMed ID: 30440025
[TBL] [Abstract][Full Text] [Related]
9. Impact of Inverted Terminal Repeat Integrity on rAAV8 Production Using the Baculovirus/Sf9 Cells System.
Savy A; Dickx Y; Nauwynck L; Bonnin D; Merten OW; Galibert L
Hum Gene Ther Methods; 2017 Oct; 28(5):277-289. PubMed ID: 28967288
[TBL] [Abstract][Full Text] [Related]
10. Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV.
Fan PD; Dong JY
Hum Gene Ther; 1997 Jan; 8(1):87-98. PubMed ID: 8989998
[TBL] [Abstract][Full Text] [Related]
11. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
[TBL] [Abstract][Full Text] [Related]
12. A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells.
Smith RH; Levy JR; Kotin RM
Mol Ther; 2009 Nov; 17(11):1888-96. PubMed ID: 19532142
[TBL] [Abstract][Full Text] [Related]
13. Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups.
Rabinowitz JE; Bowles DE; Faust SM; Ledford JG; Cunningham SE; Samulski RJ
J Virol; 2004 May; 78(9):4421-32. PubMed ID: 15078923
[TBL] [Abstract][Full Text] [Related]
14. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.
Conway JE; Rhys CM; Zolotukhin I; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
Gene Ther; 1999 Jun; 6(6):986-93. PubMed ID: 10455400
[TBL] [Abstract][Full Text] [Related]
15. Novel tools for production and purification of recombinant adenoassociated virus vectors.
Grimm D; Kern A; Rittner K; Kleinschmidt JA
Hum Gene Ther; 1998 Dec; 9(18):2745-60. PubMed ID: 9874273
[TBL] [Abstract][Full Text] [Related]
16. Generation and characterization of adeno-associated virus producer cell lines for research and preclinical vector production.
Martin J; Frederick A; Luo Y; Jackson R; Joubert M; Sol B; Poulin F; Pastor E; Armentano D; Wadsworth S; Vincent K
Hum Gene Ther Methods; 2013 Aug; 24(4):253-69. PubMed ID: 23848282
[TBL] [Abstract][Full Text] [Related]
17. Selective Rep-Cap gene amplification as a mechanism for high-titer recombinant AAV production from stable cell lines.
Liu X; Voulgaropoulou F; Chen R; Johnson PR; Clark KR
Mol Ther; 2000 Oct; 2(4):394-403. PubMed ID: 11020356
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a novel cell line for the enhanced production of recombinant adeno-associated virus vectors for gene therapy.
Satkunanathan S; Wheeler J; Thorpe R; Zhao Y
Hum Gene Ther; 2014 Nov; 25(11):929-41. PubMed ID: 25072415
[TBL] [Abstract][Full Text] [Related]
19. Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids.
Booth MJ; Mistry A; Li X; Thrasher A; Coffin RS
Gene Ther; 2004 May; 11(10):829-37. PubMed ID: 14985784
[TBL] [Abstract][Full Text] [Related]
20. Production and purification of recombinant adeno-associated vectors.
Wang L; Blouin V; Brument N; Bello-Roufai M; Francois A
Methods Mol Biol; 2011; 807():361-404. PubMed ID: 22034039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
